FDA Warning & Recall Information

Baxter Hillrom is recalling their Incontinence Management System after reports that the radiofrequency emissions form the device could interfere with other vital medical equipment. The WatchCare Incontinence Management System (IMS) is designed to detect moisture through Centrella, Progressa, and VersaCare hospital beds and disposable incontinence […]

Boston-based Whele, LLC voluntarily recalled more than 500,000 of their Mighty Bliss Electric Heating Pad units after receiving numerous product safety concerns from consumers. The recall was announced on October 28th, 2022, and applies to units manufactured from Jan. 2021 – Jan. 2022 that were […]

The FDA recently requested additional details on a number of Philips Respironics Trilogy Ventilators that are experiencing new potential issues after they were reworked as part of a June 2021 recall. The initial recall involved millions of ventilator and sleep apnea devices with defects that […]

After three recalls by the U.S. Food and Drug Administration (FDA) and the shuttering of its facility, Florida pharmaceutical company PharmaTech LLC is now the subject of seven stool softener lawsuits, several involving the death of an infant. Diocto Liquid PharmaTech LLC, the maker of […]

The U.S. Food and Drug Administration (FDA) approved Xeljanz and Xeljanz XR on November 6, 2012, and February 23, 2016, respectively. Both drugs are made by Pfizer, Inc. and were approved to treat moderate to severe active rheumatoid arthritis. Rheumatoid arthritis (RA) is the most […]

The U.S. Food and Drug Administration (FDA) approved Ocaliva (obeticholic acid) on May 31, 2016, to treat primary biliary cholangitis (PBC), a chronic liver condition resulting from destruction of the bile ducts in the liver. When the bile ducts are impaired, bile builds up in […]

The U.S. Food and Drug Administration (FDA) approved Trulicity, a type 2 diabetes drug manufactured by Eli Lilly & Company, on September 18, 2014. The drug in combination with diet and exercise is intended to improve glycemic control in adults with type 2 diabetes mellitus. […]

The U.S. Food and Drug Administration (FDA) approved Qvar (beclomethasone dipropionate hfa) on September 15, 2000, for the treatment of asthma. Qvar is a steroid manufactured by Teva Pharmaceutical Industries, Ltd. that works directly in the lungs to ease breathing by reducing the irritation and […]

The FDA warns that Latuda, a drug used to treat major depressive episodes, could lead to a serious condition called hyponatremia which occurs when water and sodium are out of balance in the body. Latuda is manufactured by Sunovion Pharmaceuticals Inc. The U.S. Food and Drug Administration (FDA) approved Latuda on October […]

The U.S. Food and Drug Administration (FDA) approved Marinol (dronabinol) on May 31, 1985, for the treatment of anorexia nervosa associated with weight loss in patients with AIDS, and chemotherapy-induced nausea and vomiting (CINV). Marinol is manufactured by Unimed Pharmaceuticals, a subsidiary of Solvay Pharmaceuticals, and is usually prescribed […]

Victoza is an injectable drug that was approved on January 25, 2010, to treat type 2 diabetes mellitus. Developed by Novo Nordisk, Victoza is similar to the natural hormone GLP-1 and helps maintain blood sugar, insulin levels, and digestion. Used with diet and exercise, the […]

The U.S. Food and Drug Administration (FDA) approved Ofev (nintedanib) capsules for the treatment of idiopathic pulmonary fibrosis (IPF) on October 15, 2014. IPF is a rare and fatal lung disease that affects as many as 132,000 patients in the U.S.  Pulmonary fibrosis is a […]